Susquehanna International Group, LLP Aquestive Therapeutics, Inc. Put Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$2.4 - $5.09 $24,720 - $52,427	-10,300 Reduced 6.54%	147,200 $733,000
Q2 2024 Aug 15, 2024	SELL	$2.31 - $4.5 $381,843 - $743,850	-165,300 Reduced 51.21%	157,500 $409,000
Q1 2024 May 07, 2024	BUY	$2.01 - $6.09 $564,407 - $1.71 Million	280,800 Added 668.57%	322,800 $1.38 Million
Q4 2023 Feb 14, 2024	BUY	$1.29 - $2.47 $38,184 - $73,112	29,600 Added 238.71%	42,000 $84,000
Q3 2023 Nov 14, 2023	BUY	$1.5 - $2.24 $18,600 - $27,776	12,400 New	12,400 $18,000

122

46.8M

517K

207K

Ticker AQST
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,350,700
Market Cap $237M
Description
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.